| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5173(00)00669-4 |
| P698 | PubMed publication ID | 11250095 |
| P2093 | author name string | Yu SY | |
| Tsai YH | |||
| Wu PC | |||
| Fang JY | |||
| Huang YB | |||
| P2860 | cites work | A Simple Method for the Preparation of Liposomes for Pharmaceutical Applications: Characterization of the Liposomes | Q31043387 |
| Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model | Q35341809 | ||
| Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints | Q37787758 | ||
| Non-ionic surfactant based vesicles (niosomes) in drug delivery | Q57610510 | ||
| Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry | Q57610520 | ||
| Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids | Q68670211 | ||
| Mechanism for enhancement effect of lipid disperse system on percutaneous absorption | Q71795050 | ||
| Liposomes as carriers for topical and transdermal delivery | Q72430428 | ||
| Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers | Q74533947 | ||
| Proniosome based transdermal delivery of levonorgestrel for effective contraception | Q77184316 | ||
| Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis | Q77390744 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 91-99 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | In vitro skin permeation of estradiol from various proniosome formulations | |
| P478 | volume | 215 |
| Q38152812 | A review on novel vesicular drug delivery: proniosomes |
| Q46358000 | Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. |
| Q41500018 | Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design |
| Q40713954 | Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. |
| Q49478316 | Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations. |
| Q35844751 | Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide-maltodextrin complex |
| Q28709364 | Development of a novel niosomal system for oral delivery of Ginkgo biloba extract |
| Q46217154 | Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment |
| Q51941052 | Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. |
| Q53749395 | Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. |
| Q46732851 | Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study |
| Q36144221 | Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems. |
| Q46416602 | Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery |
| Q40851890 | Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept |
| Q43090877 | Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. |
| Q53089921 | Formulation and evaluation of proniosomes containing lornoxicam. |
| Q42326600 | Formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design |
| Q51756206 | Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. |
| Q64972547 | Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition. |
| Q41083456 | Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment |
| Q42753033 | In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin |
| Q34293795 | In vitro evaluation of proniosomes as a drug carrier for flurbiprofen |
| Q31116193 | Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters |
| Q42429675 | Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans |
| Q35155299 | Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions. |
| Q37909120 | Liposomal systems as drug delivery vehicles for dermal and transdermal applications |
| Q36193206 | Liposomes and niosomes as topical drug delivery systems |
| Q42945594 | Microemulsion system with improved loading of piroxicam: a study of microstructure. |
| Q34882750 | Microemulsions as a surrogate carrier for dermal drug delivery. |
| Q44353164 | Microemulsions for topical delivery of estradiol |
| Q46754307 | Nano-proniosomes enhancing the transdermal delivery of mefenamic acid |
| Q38835591 | Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design |
| Q35567800 | Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation |
| Q42733018 | Niosome as a drug carrier for topical delivery of N-acetyl glucosamine |
| Q60959464 | Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier |
| Q37618808 | Niosomes in sustained and targeted drug delivery: some recent advances. |
| Q46902877 | Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits. |
| Q46202238 | Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation. |
| Q46489252 | Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain |
| Q41773706 | Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery |
| Q35013281 | Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs |
| Q39456079 | Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition |
| Q63213340 | Proniosomes as a novel drug carrier system for buccal delivery of benzocaine |
| Q47355869 | Proniosomes derived niosomes: recent advancements in drug delivery and targeting. |
| Q48925161 | QbD-Based Development and Validation of a Stability-Indicating HPLC Method for Estimating Ketoprofen in Bulk Drug and Proniosomal Vesicular System. |
| Q35208156 | QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes |
| Q38128395 | Recent advances in gel technologies for topical and transdermal drug delivery. |
| Q38155210 | Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. |
| Q35126324 | Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy |
| Q40612521 | Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. |
| Q38705821 | Technology overview and drug delivery application of proniosome |
| Q37290722 | Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder |
| Q39923327 | Tween-embedded microemulsions--physicochemical and spectroscopic analysis for antitubercular drugs. |
| Q37854064 | Water-in-oil microemulsions for effective transdermal delivery of proteins |
Search more.